FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to stable alpha-melatotropin (α-MSH) peptide analogues which have affinity for melanocortin 1 receptor (MC1R), to pharmaceutical preparations of α-MSH peptide analogues, as well as to methods for using these analogues for treating the MC1R-related diseases in medicine and veterinary science.
EFFECT: preparing the stable alpha-melatotropin peptide analogues.
16 cl, 26 dwg, 2 tbl, 23 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ALPHA- AND GAMMA-MSH ANALOGUES | 2013 |
|
RU2668791C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| USE OF LONG-ACTING GLP-1 PEPTIDES | 2013 |
|
RU2657573C2 |
| PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2690377C2 |
| PARATHYROID HORMONE ANALOGS AND USES THEREOF | 2011 |
|
RU2604809C2 |
| FUSED DRUG CONSTRUCTS AND CONJUGATES | 2005 |
|
RU2428431C2 |
| COMPOSITION CONTAINING PROBIOTICS AND POLYPEPTIDE HAVING BINDING AFFINITY RELATIVELY TO IgE AND ITS USE | 2019 |
|
RU2786578C2 |
| INTERLEUKIN 15 PROTEIN COMPLEX AND USE THEREOF | 2015 |
|
RU2711979C2 |
| DIRECTED REGENERATION OF BROKEN BONE BY MEANS OF STIMULATION OF PARATHYROID HORMONE RECEPTOR | 2017 |
|
RU2785401C2 |
| GLUCAGON ANALOGUES, POSSESSING HIGHER SOLUBILITY AND STABILITY IN BUFFERS WITH PHYSIOLOGICAL Ph VALUES | 2009 |
|
RU2560254C2 |
